Search hospitals > Colorado > Aurora

Barbara Davis Center for Childhood Diabetes

Claim this profile
Aurora, Colorado 80045
Global Leader in Type 1 Diabetes
Global Leader in Diabetes
Conducts research for Low Blood Sugar
Conducts research for Type 2 Diabetes
Conducts research for High Cholesterol
113 reported clinical trials
12 medical researchers
Photo of Barbara Davis Center for Childhood Diabetes in AuroraPhoto of Barbara Davis Center for Childhood Diabetes in AuroraPhoto of Barbara Davis Center for Childhood Diabetes in Aurora

Summary

Barbara Davis Center for Childhood Diabetes is a medical facility located in Aurora, Colorado. This center is recognized for care of Type 1 Diabetes, Diabetes, Low Blood Sugar, Type 2 Diabetes, High Cholesterol and other specialties. Barbara Davis Center for Childhood Diabetes is involved with conducting 113 clinical trials across 23 conditions. There are 12 research doctors associated with this hospital, such as Andrea Steck, MD, Peter Gottlieb, MD, Robert Slover, MD, and Sarit Polsky, MD.

Area of expertise

1Type 1 Diabetes
Global Leader
Barbara Davis Center for Childhood Diabetes has run 95 trials for Type 1 Diabetes. Some of their research focus areas include:
IA-2 positive
ZnT8 positive
Stage 2
2Diabetes
Global Leader
Barbara Davis Center for Childhood Diabetes has run 86 trials for Diabetes. Some of their research focus areas include:
IA-2 positive
ZnT8 positive
Stage 2

Top PIs

Clinical Trials running at Barbara Davis Center for Childhood Diabetes

Type 1 Diabetes
Diabetes
Dermatomyositis
Myositis
Inflammatory Myositis
Image of trial facility.

Hybrid Closed Loop System

for Type 1 Diabetes

This study is evaluating whether a new type of insulin pump may help improve blood sugar control in people with type 1 diabetes.
Recruiting1 award N/A17 criteria
Image of trial facility.

Fully Closed Loop System

for Type 1 Diabetes

Protocol Overview/Synopsis This study will be conducted at 3 sites, with each site performing a session with up to 6 participants with a lower HbA1c (<8.0%) in one of 3 age categories (26-60, 18-25, or 14-17 years) followed by a session of up to 6 additional participants with a higher HbA1c (8.0-12.0%) with the same age categories (26-60, 18-25, or 14-17 years). The trial will aim to complete a total of 36 participants: 12 total participants within each age category and 18 participants within each HbA1c category; 12 participants at each site. The study may enroll up to 70 participants to account for dropouts across the study. The study will be performed for 5 days and 4 nights at a local hotel/rental. Following the hotel session, participants will undergo a 7 day/6-night remote monitored at-home use session. The study will also conduct a two-week control period gathering data on glycemic control and insulin administration with the participants usual care therapy. Participants will be randomized 1:1, stratified by age cohort, to either group A (control period prior to AIDANET use) or group B (control period after AIDANET use).
Recruiting1 award N/A17 criteria
Image of trial facility.

Rituximab + Abatacept

for Type 1 Diabetes

The study is a two-arm, multicenter, double-blinded clinical trial testing sequential therapy with rituximab-pvvr followed by abatacept versus rituximab-pvvr alone in new onset T1D. The primary objective is to test whether the C-peptide response to a 2-hour mixed meal tolerance test, will be improved in participants with new onset T1D who are treated with Abatacept after Rituximab-pvvr compared to those treated with Rituximab-pvvr and placebo 24 months after enrollment.
Recruiting0 awards Phase 220 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Barbara Davis Center for Childhood Diabetes?
Barbara Davis Center for Childhood Diabetes is a medical facility located in Aurora, Colorado. This center is recognized for care of Type 1 Diabetes, Diabetes, Low Blood Sugar, Type 2 Diabetes, High Cholesterol and other specialties. Barbara Davis Center for Childhood Diabetes is involved with conducting 113 clinical trials across 23 conditions. There are 12 research doctors associated with this hospital, such as Andrea Steck, MD, Peter Gottlieb, MD, Robert Slover, MD, and Sarit Polsky, MD.